Idexx Laboratories (IDXX) Revenue (2009 - 2026)

Idexx Laboratories' Revenue history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Revenue rose 14.26% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.4 billion (up 13.08% YoY), while the FY2025 annual figure was $4.3 billion, up 10.42% from the prior year.
• Revenue was $1.1 billion for Q1 2026 at Idexx Laboratories, up from $1.1 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.1 billion in Q1 2026 to a low of $828.6 million in Q4 2022.
• Historically, Revenue has averaged $963.0 million across 5 years, with a median of $954.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue climbed 3.43% in 2022, then rose 14.28% in 2025.
• A 5-year view of Revenue shows it stood at $828.6 million in 2022, then climbed by 8.81% to $901.6 million in 2023, then gained by 5.84% to $954.3 million in 2024, then climbed by 14.28% to $1.1 billion in 2025, then advanced by 4.61% to $1.1 billion in 2026.
• The last three Revenue figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.